DescriptionLiterature has shown that prescribers receive little education on the treatment of pain, resulting in less effective pain treatment with worse outcomes. Attendees will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain, and recognizing substance use/opioid use disorders. This program will include the three required topics outlined by the new CME requirement in 21 NCAC 32R .0101:
• Controlled substances prescribing practices
• Recognizing signs of the abuse or misuse of controlled substances
• Controlled substance prescribing for chronic pain management
As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirements as set forth by their licensing boards; requirements vary by discipline and board. Physicians must follow the CME requirement per 21 NCAC 32R .0101 and will turn in record of controlled substance CME when they renew licensure.
Same course content, alternate date: October 30, 2018
MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.
The program is recommended for physicians, physician assistants, pharmacists, nurse practitioners, and podiatrists.
Upon completion of this knowledge based educational activity, participants will be able to:
- Describe the impact of the opioid crisis
- Identify the CDC guidelines for prescribing opioids for acute pain
- Identify the CDC guidelines for prescribing opioids for chronic pain
- Discuss what to do with patients on opioids that fall outside the guidelines
- Susan McDowell, MD
19ME020 - Treating Pain Safely: Fewer Opioids and Better Results Controlled Substances Education for Prescribers
4/4 5:30 PM–8:45 PM
MAHEC designates this continuing education activity as meeting the criteria for 0.30 CEUs as established by the National Task Force on the Continuing Education Unit. You must attend the entire workshop to receive CEUs.
3.000 Contact Hours
MAHEC designates this continuing education activity as meeting the criteria for 3.0 Contact Hours. Full attendance is required to receive credit.
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program ACPE# 0046-9999-18-295-L04-P will provide 3.0 Contact Hours of continuing education.
3.000 AMA PRA Category 1 Credit
Accreditation The Mountain Area Health Education Center (MAHEC) is accredited by the North Carolina Medical Society (NCMS) to provide continuing medical education for physicians. Credit Designation MAHEC designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This course will offer 3.0 AMA PRA Category 1 Credit(s)™ which will fulfill the North Carolina Medical Board's requirement of controlled substance continuing education. Disclosure MAHEC adheres to the ACCME Standards regarding industry support to continuing medical education. Disclosure of faculty and commercial support relationships, if any, will be made known at the time of the activity.